This Note addresses the issues related to fertility preservation treatments for cancer patients in the context of insurance coverage. As cancer survival rates improve, the ability to bear children after therapy is increasingly difficult and a concern for most patients. Currently, no states have laws requiring insurance coverage for fertility preservation treatments for cancer patients. Because it is not currently covered by either private or public insurance, only those who can pay for it on their own can use fertility preservation treatments. This note proposes that Massachusetts, as having one of the most inclusive infertility health insurance mandates, should expand insurance coverage to those who may become infertile because of cancer treatments. Such an expansion would ensure that cancer patients can receive fertility preservation treatment prior to commencing chemotherapy or radiation. This Note argues that insurance coverage should be extended because it improves a cancer patient’s quality of life, and will promote consistency, fairness, and equality. Further, this Note explores the constitutional implications of oncofertility.
"Maria’s Law: Extending Insurance Coverage for Fertility Preservation to Cancer Patients in Massachusetts,"
University of Massachusetts Law Review: Vol. 9
, Article 5.
Available at: http://scholarship.law.umassd.edu/umlr/vol9/iss2/5